|
|
||||||||

* Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, AB, Canada T6G 2P5
Department of Animal Science, University of Helsinki, 00014 Finland
1 Corresponding author: john.kennelly{at}ualberta.ca
| ABSTRACT |
|---|
|
|
|---|
Key Words: conjugated linoleic acid bovine milk fat safflower flaxseed
| INTRODUCTION |
|---|
|
|
|---|
The CLA found in ruminant meat and milk appears to originate either directly from the rumen or by tissue desaturation of rumen-derived trans-11 18:1. In the rumen, isomers of CLA and trans 18:1 are produced as intermediates in the biohydrogenation of unsaturated FA (Kepler et al., 1966). It has been suggested that little cis-9, trans-11 CLA actually accumulates in the rumen and that the majority of milk CLA is derived from trans-11 18:1 in the mammary gland through the action of
9-desaturase (Griinari et al., 2000). Therefore, factors that increase the level of trans-11 18:1 synthesized in the rumen would be expected to increase milk CLA.
Diet is by far the most influential factor determining the concentration of CLA in bovine milk fat (Griinari and Bauman 1999; Chilliard et al. 2000). The objective of this study was to evaluate the effect of various combinations of safflower oil, flaxseed oil, monensin, and vitamin E on the concentration of CLA in the bovine milk. Safflower oil and flaxseed oil were chosen for their high content of cis-9, cis-12 18:2 and cis-9, cis-12, cis-15 18:3, respectively. Monensin and vitamin E, although not adding substrates for CLA or trans-11 18:1 production, were chosen for their potential effect on the biohydrogenation process. Fellner et al. (1997) studied the effects of ionophores on lipid biohydrogenation using a continuous culture system. They found that the antiporter ionophores monensin, nigericin, and tetronasin interfered with the biohydrogenation of cis-9, cis-12 18:2. The study showed that ionophores caused a reduction in the extent of cis-9, cis-12 18:2 biohydrogenation with an accumulation of intermediate products, including CLA. They followed up this work in dairy cows by evaluating the effect of monensin at 24 mg/kg of dietary DM on milk CLA over a 28-d period (Sauer et al., 1998). They observed a small but significant increase in CLA from 0.8 to 1.3% of milk fat. Other studies have failed to show a benefit of ionophores for enriching the concentration of CLA in milk fat (Chouinard et al., 1998; Dhiman et al., 1999). Therfore, the usefulness of ionophores to enhance milk CLA is considered equivocal. Previous researchers have shown that dietary vitamin E was capable of reducing the extent of diet-induced milk fat depression (Charmley and Nicholson, 1993, 1994; Focant et al., 1998). Milk fat depression is associated with a shift in rumen biohydrogenation, characterized by increased formation of trans-10 18:1 (Bauman and Griinari, 2001). Thus, it is possible that the alleviation of this depression by vitamin E is brought about by a shift in rumen biohydrogenation toward pathways that produce trans-11 18:1 and away from trans-10 18:1. Apart from increased milk fat percentage, this could also provide more trans-11 18:1 for mammary CLA synthesis.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Experiment 1
Animals and Treatments.
Twenty-eight lactating Holstein cows (8 primiparous, 20 multiparous) were used in a randomized complete block design with repeated measures. The animals averaged 213 ± 61 DIM at the start of the trial with an average BW of 607 ± 57.8 kg and an average BCS of 2.77 ± 0.46 (5-point scale). All cows were first fed a control diet for 8 d (wk 0). Animals were then blocked according to parity and DIM and randomly placed into one of 4 groups. Each group was fed one of 4 diets for a 15-d treatment period: 1) control diet; 2) control diet including monensin supplemented at 24 ppm of DM (MON); 3) control diet including safflower oil supplemented at 6% of DM (SAFF); 4) control diet including safflower oil supplemented at 6% of DM plus monensin supplemented at 24 ppm of DM (SAFF/M). The supplementary ingredients were added to their respective concentrates prior to addition of forages by thorough mixing in Calan data rangers in 500-kg batches. All diets were formulated to meet or exceed NRC (1989) recommendations.
Cows were housed in tie stalls, and water was available at all times. The diets were fed once per day at 0900 h as a TMR consisting of 60% forage and 40% concentrate (Table 1
). Feed intake was recorded daily and adjusted to maintain 5 to 10% orts. Milking was carried out twice per day starting at 0330 and 1430 h. Milk yield was recorded daily.
|
Milk was sampled from each cow at a.m. and p.m. milkings on the last 2 d of wk 0 and the last 2 d of the treatment period. The amount sampled at each milking was proportional to the milk yield. The a.m. and p.m. samples were then combined to give one sample for each cow on each sampling day. A portion of milk from each cow was preserved with potassium dichromate and analyzed for protein, fat, lactose, and SCC using near infrared spectroscopy (AOAC, 1996; method 972.16) at the Alberta Agriculture, Food and Rural Development Central Milk Testing Laboratory (Edmonton, Alberta, Canada). The rest of the milk was stored at 20°C for later analysis.
Lipids for FA analysis were extracted from the milk using chloroform:methanol (2:1; Folch et al., 1957). The milk was thawed at 27°C. A 2-mL sample of the thawed milk was placed in a 50-mL tube. Twenty-four milliliters of chloroform:methanol (2:1) was added. The tube was capped, shaken for 30 s by hand, and allowed to stand for at least 1 h. Eight milliliters of 0.8% NaCl (wt/vol) was added, and the tube stood overnight at 4°C. The tube was then warmed to room temperature and centrifuged at approximately 1,500 x g for 5 min. The upper methanol:water layer was removed using a water aspirator and discarded. Ten milliliters of the lower chloroform phase was transferred to a 20-mL glass scintillation vial. The chloroform was evaporated at 40°C under nitrogen leaving the fat (~20 to 30 mg).
The FA were then methylated by sodium methoxide using a procedure similar to that described by Chouinard et al. (1999), which was based on the method of Christie (1982). Two milliliters of hexane was added to the 20-mL glass scintillation vial to resolubilize the fat. From this, a volume representing approximately 5 mg of fat was removed and placed in a 14-mL screw-top test tube. Twenty microliters of methyl acetate was added. Following vortexing, 40 µL of methylating agent (0.5 M sodium methoxide) was added. The mixture was vortexed and allowed to react for 10 min at room temperature. The reaction was stopped with 30 µL of termination reagent (1 g of oxalic acid in 30 mL of diethyl ether). The sample was then centrifuged at 2,400 x g for 5 min, leaving a clear layer of hexane from which an aliquot was taken for gas chromatography analysis.
The FA methyl esters (FAME) were analyzed on a Varian 3600 gas chromatograph (Varian Chromatography Systems, Walnut Creek, CA) with a temperature-programmable injector and flame-ionization detector. Separation of the FAME was performed using a CP-Sil 88 fused silica capillary column [50 m x 0.25 mm (i.d.) with 0.25-µm film thickness] (Chrompack, Middelburg, The Netherlands). Purified Helium (Praxair, Edmonton, Canada) was used as the carrier gas with a head pressure of 25 psi and a flow rate of 1 mL/min. The initial column temperature was set at 50°C and held for 0.1 min, increased to 180°C at 25°C/min and held for 1 min, further increased to 190°C at 2°C/min and held for 2 min, and finally increased to 230°C at 10°C/min and held for 7 min. The initial injector temperature was 90°C, increasing at 150°C/min to 240°C and held for 23 min. The detector temperature was set at 240°C. Peak area was measured using the Shimadzu Class-VP chromatography data system (Shimadzu Scientific Instruments Inc., Columbia, MD). Peaks were identified using Nu-Chek Prep standards #85 and #411. Conjugated linoleic acid isomers were identified using standards from Matreya (Matreya, Inc., PA). Detector response for individual FA was verified using Nu-Chek Prep standard #60 (Nu Chek Prep). Each FA was reported as a percentage of FAME.
Experiment 2
Animals and Treatments.
Sixty-two (28 primiparous, 34 multiparous) lactating Holstein cows were used in a randomized complete block design with repeated measures. Animals were blocked according to parity and DIM. Cows within each block were then randomly assigned to one of 6 diets (10 or 11 cows per diet): 1) control diet, 2) SAFF, 3) SAFF/E, 4) SAFF/M; 5) control diet including safflower oil at 6% of DM plus monensin at 24 ppm of DM plus vitamin E at 150 IU/kg of DM (SAFF/ME), and 6) control diet including flaxseed oil at 6% of DM plus vitamin E at 150 IU/kg of DM (FLAX/E). The supplementary ingredients were added to their respective concentrates prior to addition of forages by thorough mixing in Calan data rangers in 500-kg batches. All diets were formulated to meet or exceed NRC (1989) recommendations.
Cows were housed in tie stalls, and water was available at all times. The diets were fed once per day at 0900 h as a TMR consisting of 60% forage and 40% concentrate (Table 2
). Feed intake was recorded daily and adjusted to maintain 5 to 10% orts. The control diet was fed initially to all cows for 10 d (wk 0). Cows then received their respective diets for a period of 9 wk. Cows were adapted to dietary change over a 3-d period. Milking was carried out twice daily starting at 0330 and 1430 h. Milk yield was recorded daily. Body weight was recorded once per week after a.m. milking, and BCS was estimated on a 5-point scale at the end of wk 0, 3, 6, and 9.
|
Milk was sampled as described for Experiment 1 from each cow at a.m. and p.m. milking on the last day of wk 0, 2, 4, and 8. As with Experiment 1, a portion of milk from each cow was preserved with potassium dichromate and analyzed for protein, fat, lactose, and SCC using near infrared spectroscopy at the Alberta Agriculture, Food and Rural Development Central Milk Testing Laboratory. The rest of the milk was stored at 20°C for later analysis.
Lipids for FA analysis were extracted from the milk as described for Experiment 1. The FA were then methylated as per Experiment 1 with minor modifications. Two milliliters of hexane was added to the 20-mL glass scintillation vial to resolubilize the fat. The hexane containing the fat was then transferred into a 14-mL screw-top tube. Forty microliters of methyl acetate was added. Following vortexing, 80 µL of methylating agent (0.5 M sodium methoxide) was added. The mixture was vortexed and incubated for 15 min in a 50°C water bath. The reaction was stopped by adding 60 µL of termination reagent (1 g of oxalic acid in 30 mL of diethyl ether). Two milliliters of water was added to remove any nonlipid material. The sample was vortexed and centrifuged at 2,400 x g for 5 min, leaving a clear layer of hexane from which an aliquot was taken for gas chromatography analysis.
The FAME were analyzed on a Varian 3600 gas chromatograph with a temperature-programmable injector and flame-ionization detector. Separation of the FAME was performed using an SP2560 fused silica capillary column [100 m x 0.25 mm (i.d.) with 0.25-µm film thickness] (Supelco). Purified helium (Praxair) was used as the carrier gas with a head pressure of 25 psi and a flow rate of 1 mL/min. The initial column temperature was set at 40°C and held for 4 min, increased to 175°C at 13°C/min and held for 25 min, further increased to 215°C at 4°C/min and held for 23 min, and finally increased to 230°C at 5°C/min and held for 17.5 min. The initial injector temperature was 60°C, held for 0.2 min, then increased at 150°C/min to 250°C and held for 88 min. The detector temperature was set at 250°C. Peak area was measured using the Shimadzu Class-VP chromatography data system. Peaks were identified using Nu-Chek Prep standards #85 and #411. Conjugated linoleic acids isomers were identified using standards from Matreya. Trans-11, cis-15 18:2 was identified by cross-referencing with previously published isomeric profiles reported for milk fat produced under similar analytical conditions (Ulberth and Henninger, 1994; Precht and Molkentin, 1997) using cis-9, cis-12 18:2 as a landmark isomer. Detector response for individual FA was verified using Nu-Chek Prep standard #60. Each FA was reported as a percentage of FAME.
Separation of the octadecenoic acids was carried out on milk samples collected during wk 0, 2, 4, and 8 using a gas chromatograph (5890; Hewlett-Packard, Wilmington, DE) equipped with a flame-ionization detector, automatic injector, split injection port, and a 100-m fused silica capillary column (i.d. = 0.25 mm) coated with 0.2-µm film of cyanopropyl polysiloxane (CP-SIL 88, Chrompack). Helium was used as the carrier gas. Injector and detector temperatures were maintained at 240 and 260°C, respectively, and the sample (1 µL) was injected using split ratio of 1:50. The FAME profile of octadecenoic acids was determined using the following temperature program. Column temperature was maintained at 70°C for 1 min, increased to 170°C at a rate of 30°C/min, and held at this temperature for 54 min. As a final step, column temperature was increased to 220°C at a rate of 30°C/min and held at this temperature for 15 min. Separation of trans and cis octadecenoic acids was incomplete, but the chromatography allowed the major isomers of interest to be resolved. Trans-6, trans-7 and trans-8 18:1 isomers, as well as trans-13 and trans-14 18:1 isomers remained unresolved as single peaks. Individual trans isomers were identified by cross-referencing with previously published isomeric profiles reported for milk fat produced under similar analytical conditions (Precht and Molkentin, 1997; Griinari et al., 1998; Precht et al., 2001) using trans-11 18:1 as a landmark isomer.
Milk for vitamin analysis was stored in opaque containers at 20°C, and vitamin extraction and preparation were performed away from direct sunlight. Vitamin E was extracted from milk using a method adapted from the procedure of Brubacher et al. (1985). Milk was thawed at 27°C. A 5-mL sample of the thawed milk was placed in a 50-mL tube. Twenty-five milliliters of methanol (containing 1.25 g of ascorbic acid and 5 mg of butylated hydroxytoluene) was added. After the addition of 5 mL of potassium hydroxide (50%, wt/vol in water), the tube was flushed with nitrogen and capped. The tube was inverted to mix contents, placed in an 80°C water bath for 20 min with periodic agitation, and then cooled to 30°C. The vitamin E was then extracted using heptane (Hidiroglou, 1989; Jensen and Nielsen, 1996). Five milliliters of heptane was added to the tube followed by vortexing for 1 to 2 min. The phases were then separated by centifugation at 1,500 x g for 5 min. The heptane layer was transferred to a 20-mL scintillation vial and evaporated under nitrogen at 40°C. The extraction procedure was repeated with another 5 mL of heptane, which was transferred to the same scintillation vial for evaporation. After evaporation, the residue was dissolved in 500 µL of acetone:chloroform (3:7, vol/vol) and transferred to an HPLC vial for immediate analysis.
Vitamin E was analyzed using a Waters 2690 HPLC system (Waters Associates Inc, Milford, MA) fitted with a Supelcosil RP LC-18 column (15 cm x 4.6 mm x 3 µm; Supelco Canada Ltd., Oakville, ON, Canada). The mobile phase was acetonitrile:methanol (75:25, vol/vol) with a flow rate of 1 mL/min at a run time of 22 min. Vitamin E was determined using a Shimadzu RF-535 Fluorescence monitor (Shimadzu Scientific Instruments Inc.) with wavelength settings of 295 and 330 nm for excitation and emission, respectively. Peak area was measured using the Shimadzu Class-VP chromatography data system. Vitamin E was quantified by comparison of peak areas to a standard curve of
-tocopherol (Sigma-Aldrich, Inc., Mississauga, ON, Canada).
Statistical Analyses
Data from both experiments were analyzed statistically as a randomized block design with a repeated measures treatment structure using the MIXED procedure of SAS version 8.3 (SAS Inst., Inc., Cary, NC). Cow within treatment was the experimental unit, and week of sampling was the repeated measure. Treatment, week, block, and treatment by week interaction were fixed effects; cow was the random effect. The Kenward-Roger option was used to estimate denominator degrees of freedom. The variance-covariance matrix structure was chosen for each statistical model in a process wherein the best fit was chosen based on the Schwarzs Bayesian criterion. Least squares means were estimated and separated using the pdiff option when fixed effects were significant (P < 0.05).
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
|
|
The present study used monensin and observed an apparent synergistic effect with safflower oil in increasing the concentration of CLA in milk fat. Sauer et al. (1998) observed an effect of monensin on milk fat CLA that was similar to the effect of the MON diet in this study. However, other studies have found minimal effects (Chouinard et al., 1998; Dhiman et al., 1999). In the current study, SAFF/M diet resulted in increased levels of trans 18:1 and tended to decrease levels of 18:0 (P < 0.07) in milk fat, suggesting that the synergistic effect of SAFF and MON also involved inhibition of trans 18:1 reduction in the rumen. In the study by Sauer et al. (1998) trans 18:1 concentration in milk fat increased 3-fold when 24 ppm of monensin was added to the diet. Consistent with the importance of the endogenous synthesis of CLA from trans-11 18:1 (Griinari et al., 2000), concentration of CLA in milk fat also increased from 0.8 to 1.3% of total FA. Recently, Jenkins et al. (2003) demonstrated that addition of 25 ppm of monensin in a culture of mixed rumen bacteria resulted in inhibition of trans 18:1 reduction and minimal effect on accumulation of CLA. Thus, we conclude that, in the current study, the combination of safflower oil and monensin demonstrates a synergistic effect in inhibiting trans-18:1 reduction in the rumen and subsequent increase in the enhancement of CLA levels in milk fat.
Diet-induced changes in rumen biohydrogenation, resulting in enhanced levels of CLA in milk fat, as discussed previously, are also associated with the decrease in milk fat percentage. The biohydrogenation theory of milk fat depression as proposed by Bauman and Griinari (2001) is based on a concept that, under certain dietary conditions, the pathways of rumen biohydrogenation are altered to produce unique FA intermediates, some of which are potent inhibitors of milk fat synthesis. The only confirmed inhibitor of milk fat synthesis, established by postruminal infusion studies, is the trans-10, cis-12 CLA (Baumgard et al., 2000). The current study finds increased levels of trans-10, cis-12 CLA in milk fat with SAFF and SAFF/M diets, similar to studies involving diet-induced milk fat depression (Piperova et al., 2000; Peterson et al., 2003). Levels of milk trans-10, cis-12 CLA are considerably lower in studies involving diet-induced milk fat depression compared with studies involving postruminal infusions of trans-10, cis-12 CLA at comparable levels of milk fat reduction, suggesting that, in addition to trans-10, cis-12 CLA, other inhibitors of milk fat synthesis may be formed in the rumen when milk fat depression is induced by the diet (Piperova et al., 2000; Peterson et al., 2003). The interaction between SAFF and MON diets observed relative to concentration of CLA is apparent with regard to the trans-10, cis-12 CLA content in milk fat, but not in terms of fat percentage change. The reason for this discrepant result cannot be explained based on available data.
Even though dairy products contribute only about 15 to 25% of the total fat in the Western diet, they provide 25 to 35% of the total saturated fat (Chilliard et al., 2000). Ruminant fat has been associated with an elevation in blood total cholesterol because of its high content of saturated FA and particularly because of its high content of 14:0 and 16:0, which are generally considered hyper-cholesterolemic (Berner, 1993). In this study, we found that diets that increased CLA also resulted in a decrease in the proportion of 14:0 and 16:0 in milk fat. The SAFF and SAFF/M milk compared with control or MON had 33 to 35% lower 14:0 and 41 to 44% lower 16:0. The level of cis-9, cis-12 18:2 was also significantly increased with SAFF and SAFF/M, although the level of this FA was still relatively low in the milk fat. This is undoubtedly because of the extensive biohydrogenation that occurs in the rumen (Doreau and Ferlay, 1994). There was no additional increase of cis-9, cis-12 18:2 in milk fat when monensin was added to the diet.
Increase in milk fat CLA content is associated with an increase in total trans FA in milk fat. Dietary trans FA increase low-density lipoprotein cholesterol and decrease high-density lipoprotein cholesterol, thus causing an unfavorable low-density:high-density lipoprotein change (Mensink and Katan, 1990). Unfortunately, there are no controlled dietary studies that compared the effect of trans FA from different sources, i.e., chemical hydrogenation or biohydrogenation. Therefore, an increase in milk fat trans FA content may have a negative impact on perceived nutritional quality of CLA-enriched milk fat. It is important to characterize the diet-induced changes in trans FA isomer profiles in more detail, and this was done in Experiment 2.
Experiment 2
Experiment 1 involved feeding the cows over a 2-wk period. However, it was not certain whether the effects of the supplemental ingredients on milk CLA would be sustained over a longer period. In particular, questions surrounded the long-term effectiveness of monensin caused by the adaptation of rumen microbes to monensin (Griinari and Bauman, 1999; Chilliard et al., 2000). Experiment 2 also considered the effectiveness of flaxseed oil to increase milk CLA compared with safflower oil and the effect of supplemental vitamin E on milk CLA concentrations.
DMI, Milk Yield and Milk Composition.
The effects of dietary treatment on DMI, milk yield, and milk composition are presented in Table 5
. All groups decreased DMI over the treatment period (week effect, P < 0.0001). The drop in DMI appeared to be more pronounced for the diets containing monensin than for the control diet, and this reached significance for SAFF/M compared with the control. This effect of monensin on DMI has been demonstrated before (Ramanzin et al., 1997; Sauer et al., 1998) and is part of the reason for improved feed efficiency observed with monensin feeding in cattle.
|
-tocopherol/d. In this experiment, the trans-10 18:1 was significantly reduced for SAFF/ME compared with SAFF/M, but was not significantly different between SAFF and SAFF/E (Table 6
|
|
Milk FA Composition.
The effect of dietary treatment on milk FA composition is shown in Table 6
. The main characteristics of the safflower oil and flaxseed oil were to some extent reflected in the milk FA composition. The addition of safflower or flaxseed oil significantly raised the level of cis-9, cis-12 18:2 in the milk compared with the control, although this was much more pronounced for the safflower diets than for the flaxseed diet. The addition of flaxseed to the diet increased the level of cis-9, cis-12, cis-15 18:3 in milk compared with the control or safflower treatments. Although a significant increase in cis-9, cis-12 18:2 and cis-9, cis-12, cis-15 18:3 was observed in milk, the overall increase in these FA in milk was relatively small, most likely because of extensive biohydrogenation in the rumen, as discussed previously.
The addition of safflower and flaxseed oil reduced the level of 16:0 and 14:0 in the milk by, on average, 40.1 and 28.1%, respectively (Table 6
). This is similar to what was observed in Experiment 1. Because 16:0 and 14:0 have been implicated as being hypercholesterolemic, the large decrease in their concentration observed in this study is an additional benefit (Noakes et al., 1996). The concentration of the short- to medium-chain FA (4:0 to 15:0) in milk were also reduced as a result of safflower and flaxseed oil feeding as is typically observed when the dairy diet is supplemented with fats and oils (Chilliard et al., 2000).
As discussed earlier, the effect of dietary treatments on milk fat CLA levels are mediated through the effects of the diet on rumen biohydrogenation, and in that respect, the accumulation of trans-11 18:1 in the rumen is the main driver for CLA synthesis in the mammary gland. Again, addition of safflower oil resulted in increases in all milk fat trans 18:1 isomers with the most pronounced increase in trans-11 18:1 (Table 6
). The proportion of total trans 18:1 increase attributable to increase in trans-11 18:1 varied between 57 and 75%, being lowest for FLAX/E and highest for SAFF/ME. Subsequent increases in milk fat cis-9, trans-11 CLA levels were similar to the levels observed in the first experiment.
Addition of monensin further increased SAFF-induced trans 18:1 accumulation in the rumen as demonstrated by significant increases in milk fat levels of total trans 18:1 (Table 6
). Cis-9, trans-11 CLA levels tended to be higher when SAFF and SAFF/E diets were supplemented with monensin. However, the difference between SAFF and SAFF/M diets did not reach significance. Detailed analysis of trans 18:1 profiles (Table 6
) revealed that the increase in total trans 18:1 compared with the control when SAFF/M was fed was attributable to a smaller increase in trans-11 18:1 (66%) and a greater increase in trans-10 18:1 (21%) compared with 72 and 7% proportional increases, respectively, in these isomers when SAFF was fed. In other words, monensin might have shifted biohydrogenation toward the pathway that produces trans-10 18:1 as an intermediate. The effect was not pronounced, and the shift was not observed in all cows, but it explains the lack of significant increase in milk fat CLA caused by monensin in experiment 2 in contrast to Experiment 1.
Proportion of trans-10 18:1 of total trans 18:1 in milk fat can be used as an indicator of the trans-10 biohydrogenation shift. In this experiment, the average proportion of trans-10 18:1 of total trans 18:1 in milk fat was 11%. When a cut-off of 20% for this ratio was used, incident cases of trans-10 shift were clearly identified. In the FLAX/E group, there were no incidences of trans-10 shift (0 cases per 30 observations), one case in the SAFF group, 6 cases in the SAFF/E group, 9 cases in the SAFF/M group, and 3 cases in the SAFF/ME group. Furthermore, most of the cases in the SAFF/E and SAFF/M groups were attributable to only 2 and 3 individual cows, respectively. With a limited number of cows in each treatment group, the effect of individual differences in susceptibility to trans-10 shift cannot be excluded. Gaynor et al. (1995) demonstrated that the cows vary in their susceptibility to change in rumen biohydrogenation in response to dietary treatments. One or more susceptible cows in one treatment group compared with another group may influence the milk CLA response markedly. This may be a consequence of the dietary treatments, but it may also reflect susceptibility of individual cows randomly assigned to each group.
Vitamin E supplementation tended to reduce the levels of total trans 18:1. The reduction reached significance when vitamin E was added to the diet with monensin (SAFF/M vs. SAFF/ME). Despite the reduction in total trans 18:1 level in milk fat caused by vitamin E in the monensin diet (SAFF/ME), level of CLA in milk was not reduced, which was consistent with no change in trans-11 18:1 levels.
The effect of flaxseed oil addition (FLAX/E) on accumulation of trans-11 18:1 in the rumen was less pronounced than the effect of safflower oil (SAFF/E). As a consequence, milk fat cis-9, trans-11 CLA levels were slightly lower with FLAX/E compared with the SAFF/E diet, although not significantly (Table 6
). However, the effect of FLAX/E and SAFF/E on total trans 18:1 plus trans-11, cis-15 18:2 in milk fat was essentially the same (17.28 and 17.29% of total FA, respectively). Thus, it appears that in this experiment, safflower and flaxseed oil resulted in accumulation of similar amounts of biohydrogenation intermediates, but the profile of biohydrogenation intermediates being formed changed. The characteristic biohydrogenation intermediates of cis-9, cis-12, cis-15 18:3, the major isomer in flaxseed oil, included trans-13/14 18:1, trans-15 18:1, and trans-11, cis-15 18:2. Trans-11, cis-15 18:2 was increased 5-fold when the FLAX/E diet was fed compared with the control; this biohydrogenation intermediate did not increase when SAFF diets were fed.
In this experiment, dietary treatments resulted in milk levels of trans-11 18:1 and cis-9, trans-11 CLA that are among the highest values published so far. Similar levels of milk enrichment have been observed in studies involving dietary supplementation with fish oil (Palmquist and Griinari, 2001) or low forage, e.g., corn silage-based diets (Bauman et al., 2000). Fish oil and corn silage-based diets modify rumen biohydrogenation and produce high levels of intermediates when plant oils are added to the diet (Griinari and Bauman, 1999). Addition of plant oils to pasture diet does not, in general, result in high levels of biohydrogenation intermediates (Kay et al., 2004.). Therefore, it is peculiar that the high-forage basal diet (Table 2
) used in this study facilitated such a pronounced effect on milk fat CLA and associated biohydrogenation intermediates. The reason for the favorable influence of the basal diet is unclear but may be due to the special mix of forages and concentrates used in this study (Table 2
). Oils and other supplemental ingredients were mixed with the concentrate prior to the addition of the concentrate to the forage portion of the TMR. This places the oils in close association with that part of the TMR with the smallest particle size, possibly minimizing the exposure time in the rumen because of a faster rate of passage. This study also used a high level of oil supplementation (6% of DM), and it is possible that very high levels of dietary C18-polyunsaturated FA inhibit trans 18:1 reduction in the rumen similar to lower levels of fish oil (<2% of DM). Chilliard et al. (2003) recently summarized studies involving high levels of soybean and linseed oil supplementation (5 to 6% of diet DM) in goats fed various types of basal forage. Addition of high levels of sunflower or linseed oil to hay or corn silage-based diets increased CLA content in milk fat up to 4%.
Only a few studies have reported effects of diet on bovine milk CLA >4% of total FA (Bauman et al., 2000; Palmquist and Griinari, 2001). These high levels of milk CLA have been produced in studies of short duration, but the effect has been transitory and typically associated with reduced milk fat percentage (Bauman et al., 2000). In the study by Bauman et al. (2000), the enrichment of milk fat CLA was transient because of biohydrogenation shifting toward trans-10 18:1 as the major intermediate. An associated increase in trans-10, cis-12 CLA formation in the rumen resulted in markedly reduced milk fat content (Bauman and Griinari, 2001).
In view of these experiences, the current study examined the effect of the dietary treatments over a period of 8 wk. The temporal pattern of milk CLA enrichment as depicted in Figure 2
demonstrates remarkable stability over the whole treatment period. Consistent with the role of trans-11 18:1 as the precursor of milk fat CLA, the levels also demonstrate a sustained increase during the treatment period (Figure 3
). Stable levels of cis-9, trans-11 CLA and trans-11 18:1 over time suggest that minimal shifts toward trans-10 18:1 occurred as observed in other studies (Abughazaleh et al., 2004). Thus, these findings are unique, in contrast with the transient changes described in other studies (Bauman et al., 2000; Abughazaleh et al., 2004). An important question regarding monensin was whether it would continue to have an effect beyond 2 wk. As can be seen from Figures 2
and 3
, the effect of monensin on cis-9, trans-11 CLA and trans-11 18:1 persisted across the 2-mo treatment period.
|
|
9-desaturase, or a combination of these. Formation of trans-11 18:1 in the rumen is a function of the overall increase in trans 18:1 accumulation in the rumen, as well as the proportion of trans-11 18:1 of total trans 18:1.
As discussed previously, many dietary treatments producing high levels of CLA also induce a shift in the major biohydrogenation pathways characterized by increased accumulation of trans-10 18:1 rather than trans-11 18:1. In this study, all treatments involving safflower oil supplementation had at least one and up to 3 cows per group with consistently low levels of milk fat CLA. In addition, one cow receiving SAFF/ME demonstrated a precipitous drop in milk CLA from 7.81 to 1.65% of total FA between wk 2 and 8. Based on detailed analysis of trans 18:1 isomer profiles, it can be concluded that all low-CLA cows, except for one individual, demonstrated an altered trans 18:1 profile with a high trans-10 18:1 to trans-11 18:1 ratio. The aberrant low-CLA cow was in the SAFF group and demonstrated a low trans-10 18:1 to trans-11 18:1 ratio in milk fat characteristic of high-CLA cows, but had a very low cis-9, trans-11 CLA to trans-11 18:1 ratio (0.22), suggesting low
9-desaturase activity.
This study demonstrated a close linear relationship between milk trans-11 18:1 and cis-9, trans-11 CLA contents (Figure 4
). Previous studies have reported a similar close relationship for different dietary conditions (Lawless et al., 1998; Griinari and Bauman, 1999). The slope of linear regression varies between data sets, and it is thought to reflect the rate of conversion between trans-11 18:1 and cis-9, trans-11 CLA (i.e.,
9-desaturase activity in a situation where the supply of preformed cis-9, trans-11 CLA is relatively low; Turpeinen et al., 2002). In the case of a ruminant animal, supply of preformed CLA would mean ruminal supply, and in the case of a monogastric animal, preformed would mean dietary supply. In the current study, the slope of the linear regression (Figure 4
) was 0.38. In comparison with this overall value, the low-CLA cow in the SAFF group demonstrates a significantly lower ratio (0.22). Chilliard et al. (2003) found a strong linear correlation between trans-11 18:1 and cis-9, trans-11 CLA across large number of experiments with a slope of 0.40. They suggest, however, that a very high concentration of trans-11 18:1 induced by diet may exceed the desaturation capacity of the mammary gland within a single study (Chilliard et al., 2003). Linearity of the trans-11 18:1 and cis-9, trans-11 CLA relationship across a wide range of trans-11 18:1 concentrations suggest that the capacity of
9-desaturase was not limiting in this experiment, even though the supply of stearic acid and its conversion to oleic acid was not reduced, as indicated by relatively unaltered concentrations of these FA (Table 6
.).
|
|
| CONCLUSIONS |
|---|
|
|
|---|
These studies clearly demonstrate the possibility for sustainable production of milk with levels of CLA up to 10 times higher than typical levels in dairy fat. The manufacture of CLA-enriched milk and milk products could supply dietary CLA at levels that may benefit health, without the need for unrealistic changes to eating habits.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
Received for publication December 28, 2004. Accepted for publication August 23, 2005.
| REFERENCES |
|---|
|
|
|---|
-tocopherol) in foodstuffs: HPLC method. Pages 97106 in Methods for the Determination of Vitamins in Food. Elsevier Appl. Sci. Publ. Ltd., London, UK.
-tocopherol for control of oxidized flavour in milk from dairy cows. Can. J. Anim. Sci. 73:381392.
-9 desaturase. J. Nutr. 130:22852291.